CME Group Inc. (CME)

Basic

  • Market Cap

    $77.34B

  • EV

    $78.83B

  • Shares Out

    359.99M

  • Revenue

    $5,337.7M

  • Employees

    3,460

Margins

  • Gross

    100%

  • EBITDA

    67.15%

  • Operating

    60.47%

  • Pre-Tax

    74.47%

  • Net

    57.13%

  • FCF

    62.03%

Returns (5Yr Avg)

  • ROA

    1.6%

  • ROE

    8.8%

  • ROCE

    7.55%

  • ROIC

    1.97%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $227.53

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    $14.87

  • Earnings (Dil)

    $8.38

  • FCF

    $9.21

  • Book Value

    $78.37

Growth (CAGR)

  • Rev 3Yr

    2.82%

  • Rev 5Yr

    6.08%

  • Rev 10Yr

    6.27%

  • Dil EPS 3Yr

    11.78%

  • Dil EPS 5Yr

    -8.74%

  • Dil EPS 10Yr

    11.38%

  • Rev Fwd 2Yr

    6.88%

  • EBITDA Fwd 2Yr

    8.18%

  • EPS Fwd 2Yr

    8.59%

  • EPS LT Growth Est

    10.03%

Dividends

  • Yield

  • Payout

    51.26%

  • DPS

    $4.3

  • DPS Growth 3Yr

    9.22%

  • DPS Growth 5Yr

    9.27%

  • DPS Growth 10Yr

    9.04%

  • DPS Growth Fwd 2Yr

    2.57%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Revenues

4,116.6

4,464.6

4,442.8

4,342.0

4,753.6

5,035.1

Other Revenues, Total

192.8

403.4

440.8

222.2

255.2

302.6

Total Revenues

4,309.4

4,868.0

4,883.6

4,564.2

5,008.8

5,337.7

Total Revenues % Chg.

18.2%

13.0%

0.3%

-6.5%

9.7%

10.4%

Gross Profit

4,309.4

4,868.0

4,883.6

4,564.2

5,008.8

5,337.7

Selling General & Admin Expenses, Total

1,126.1

1,446.5

1,491.2

1,482.1

1,456.4

1,536.4

Depreciation & Amortization

118.7

158.6

153.2

147.8

134.9

129.2

Amortization of Goodwill and Intangible Assets

130.0

314.7

311.2

237.6

227.7

227.7

Other Operating Expenses

253.4

292.1

254.6

207.3

187.1

216.8

Other Operating Expenses, Total

1,628.2

2,211.9

2,210.2

2,074.8

2,006.1

2,110.1

Operating Income

2,681.2

2,656.1

2,673.4

2,489.4

3,002.7

3,227.6

Interest Expense, Total

-157.7

-178.0

-166.2

-166.9

-162.7

-159.6

Interest And Investment Income

745.1

637.9

182.7

306.9

2,198.4

5,350.6

Net Interest Expenses

587.4

459.9

16.5

140.0

2,035.7

5,191.0

Income (Loss) On Equity Invest.

152.8

176.8

190.6

245.8

301.1

294.1

Currency Exchange Gains (Loss)

-73.6

-7.2

-9.7

40.7

13.2

13.2

Other Non Operating Income (Expenses)

-570.0

-534.9

-122.4

-88.5

-1,862.4

-4,751.0

EBT, Excl. Unusual Items

2,777.8

2,750.7

2,748.4

2,827.4

3,490.3

3,974.9

Merger & Related Restructuring Charges

Gain (Loss) On Sale Of Assets

-61.1

-26.3

546.2

Insurance Settlements

Other Unusual Items

EBT, Incl. Unusual Items

2,777.8

2,689.6

2,722.1

3,373.6

3,490.3

3,974.9

Income Tax Expense

814.1

573.8

615.7

736.7

799.3

925.4

Earnings From Continuing Operations

1,963.7

2,115.8

2,106.4

2,636.9

2,691.0

3,049.5

Minority Interest

-1.5

0.7

-1.2

-0.5

Net Income

1,962.2

2,116.5

2,105.2

2,636.4

2,691.0

3,049.5

Preferred Dividend and Other Adjustments

19.3

33.8

38.2

Net Income to Common Incl Extra Items

1,962.2

2,116.5

2,105.2

2,617.1

2,657.2

3,011.3

Net Income to Common Excl. Extra Items

1,962.2

2,116.5

2,105.2

2,617.1

2,657.2

3,011.3

Total Shares Outstanding

356.8

357.5

358.1

358.6

358.9

359.2

Weighted Avg. Shares Outstanding

342.3

357.2

357.8

358.3

358.7

358.9

Weighted Avg. Shares Outstanding Dil

343.7

358.2

358.5

358.9

359.2

359.4

EPS

5.7

5.9

5.9

7.3

7.4

8.4

EPS Diluted

5.7

5.9

5.9

7.3

7.4

8.4

EBITDA

2,929.9

3,129.4

3,137.8

2,874.8

3,365.3

3,584.5